ArticleJournal of clinical medicine2022
Survivorship of Reverse Shoulder Arthroplasty According to Indication, Age and Gender.
Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 60 citations in OpenAlex.
- Efficacy and safety of prosthetic arthroplasty of the distal radioulnar joint: a systematic review.The Journal of hand surgery, European volume · 2026Pooled it
- Whether the Indications for Reverse Shoulder Arthroplasty Should Continue to Be Expanded? A Systematic Review and Meta-Analysis.Orthopaedic surgery · 2025Pooled it
- Continuous clinical and radiological follow-up of isainlay reverse shoulder prostheses: results from the isa registry with a minimum of 1-year follow-up.Journal of shoulder and elbow arthroplasty · 2026Article
- Why do primary reverse total shoulder arthroplasties fail today? A systematic review and meta-analysis.JSES reviews, reports, and techniques · 2026Review
- Short- to midterm outcomes of stemless reverse total shoulder arthroplasty: a systematic review.Journal of shoulder and elbow arthroplasty · 2026Review
- Long-term survival outcomes following total shoulder arthroplasty: An implant-level systematic review and meta-analysis of case series and registry data with more than 13 years follow-up.Shoulder & elbow · 2026Review
- Review
- Under-reporting of sex-specific outcomes in reverse shoulder arthroplasty: a systematic review.Journal of shoulder and elbow arthroplasty · 2026Review
- Pain relief and durable outcomes after revision reverse shoulder arthroplasty for failed primary arthroplasty.Journal of shoulder and elbow arthroplasty · 2026Article
- Low glenoid neck Hounsfield units predict patients at high risk of mechanical complication after total shoulder arthroplasty.Journal of shoulder and elbow arthroplasty · 2026Article
- Gender Disparities in Shoulder Pain and Shoulder Surgery: A Current Concepts Review.Journal of clinical medicine · 2026Review
- Does the indication of reverse shoulder arthroplasty affect its outcomes? a meta-analysis.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2026Review
- Reverse shoulder arthroplasty following a diagnosis of bilateral posterior shoulder dislocation secondary to electric shock: a case report and literature review.Frontiers in surgery · 2026Article
- The effectiveness of anterior latissimus dorsi and teres major tendon transfers from subscapularis and anterosuperior cuff tears to reverse shoulder arthroplasty: a narrative review.JSES reviews, reports, and techniques · 2025Review
- Latissimus Dorsi Transfer Combined With Dynamic Biceps Rerouting for Massive Irreparable Rotator Cuff Tear.Arthroscopy techniques · 2025Article
- Preoperative insurance-mandated physical therapy does not prevent the need for shoulder arthroplasty in patients with glenohumeral osteoarthritis.JSES international · 2025Article
- Evaluation of ChatGPT's responses to frequently asked questions about shoulder arthroplasty.JSES international · 2025Article
- CT imaging findings in symptomatic patients with and without revision surgery after reverse shoulder arthroplasty.Skeletal radiology · 2025Article
- Analysis of patients with differing short-term rates of improvement and long-term rates of decline in range of motion and after anatomic and reverse total shoulder arthroplasty.JSES international · 2025Article
- Shoulder replacement in the under 55's is anatomical or reverse the best solution?EFORT open reviews · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 5 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background. The indications for reverse shoulder arthroplasty (RSA) have been widely expanded, but only a few studies report the long-term survival of these implants. Our objective was to report the long-term survivorship of a large series of RSAs implanted for different etiologies. Methods. A retrospective multicenter study including all the RSAs was performed in six shoulder-specialized centers with at least 2 years of follow up. We reviewed 1611 RSAs, operated between 1993 and 2010, including 497 cuff-tear arthropathies (CTA), 239 revision RSAs, 188 massive cuff tears (MCT), 185 fracture sequelae (FS), 183 failed previous cuff repairs (FCR), and 142 primary osteoarthritis (POA). The mean follow-up was 5.6 ± 3.9 years (range 2−20). Results. Overall, 266 RSAs (16.5%) had at least one complication leading to 64 reoperations (4.0%) and 110 revision surgeries (6.8%). The most frequent complications were infection (3.8%), instability (2.8%), and humerus-related complications (2.8%). At 10 years, the survival without revision surgery was 91.0% in primary RSAs and 80.9% in revision RSAs for failed arthroplasty (p < 0.001). In the primary RSA group, MCT and FCR led to 10-year survivals for over 95% but fracture sequelae and tumors had the lowest 10-year survivals (83.9% and 53.1%). Younger patients had a lower 10-year survival. In revision RSAs, male patients had a significantly lower survival than females (72.3% vs. 84.5% at 10 years, p = 0.020). Discussion. Primary RSA for cuff-deficient shoulders or POA leads to a high 10-year survival, but revision RSA or primary RSA for FS and tumors are at high-risk for revision. Surgeons should be aware of high rates of complications and lower survival rates of RSA in younger patients, in males, and in RSAs for revision surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.